MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-49-0003794
Osmed Formulations Private Limited - pharma in Ujjain, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹35.54 Cr
▲ 61% YoY
Net profit · FY 2025
₹2.88 Cr
Net margin 8.1%
EBITDA · FY 2025
₹5.13 Cr
EBITDA margin 14.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹55 Lakh
Company age
27 yrs
Est. 1999
Employees · EPFO
86
Provident fund records
About Osmed Formulations Private Limited
Data last updated:
Osmed Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24231MP1999PTC013737. Its GSTIN is 23AAACO6768Q1ZS (Madhya Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.14 Cr. It is led by directors Nipun Maheshwari (Whole-Time Director) and Pankaj Maheshwari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 56 – 57 Indudtrial Area Maxi Road, Ujjain, Madhya Pradesh, India – 456010.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.54 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹2.88 Cr (net margin 8.1%) and EBITDA of ₹5.13 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 17% over five years.
The company has about 86 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Osmed Formulations. As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹55 Lakh on record. Court records list 90 cases involving the company, including 78 filed by the company and 12 filed against it; 11 cases are pending.
Osmed Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-49-0003794). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website osmedformulations.com.
Company details
CIN U24231MP1999PTC013737
Registration Number 013737
Incorporation Date 08 September 1999
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-49-0003794
Recognitions & Rankings of Osmed Formulations
Contact details
Osmed Formulations Private Limited's registered office is in Ujjain, Madhya Pradesh. Its website is osmedformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address56 – 57 Indudtrial Area Maxi Road, Ujjain, Madhya Pradesh, India – 456010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Osmed Formulations Private Limited, buy the company report.
Comprehensive company report
Osmed Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Osmed Formulations operates one associated brand: Osmed Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceutical products such as tablets, capsules, and syrup in India. | osmedformulations.com |
Business activity
The main business activity of Osmed Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Osmed Formulations Private Limited, buy the company report.
Financials of Osmed Formulations Private Limited
FY 2024 filings availableOsmed Formulations Private Limited reported revenue of ₹35.54 Cr (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹35.54 Cr ▲ 61%
Net profit · FY 2025
₹2.88 Cr margin 8.1%
EBITDA · FY 2025
₹5.13 Cr margin 14.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 1%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 3%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 61% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.88 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.4% | ||||
| Net Profit Margin | 8.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Osmed Formulations Private Limited, buy the company report.
Board of directors of Osmed Formulations Private Limited
Osmed Formulations has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nipun Maheshwari | Whole-Time Director | 05 Aug 2014 | 12 Years 2 Months | Current |
| Pankaj Maheshwari | Director | 04 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Osmed Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salas Pharmaceuticals Private Limited | ₹35.84 Cr (FY 2024) | 13.0% | Patna, Bihar, India | |||
| Meridian Medicare Limited | ₹35.84 Cr (FY 2025) | 4.0% | Himachal Pradesh, India | |||
| Radicura Pharmaceuticals Private Limited | ₹35.79 Cr (FY 2025) | -5.0% | New Delhi, Delhi, India | |||
| Osmed Formulations Private Limitedthis company | ₹35.54 Cr (FY 2025) | ₹2.88 Cr | 8.1% | 61.0% | 86 | Ujjain, Madhya Pradesh, India |
| Agrawal Drugs Private Limited | ₹35.54 Cr (FY 2024) | 1.0% | Delhi, India | |||
| Somu Organo Chem Private Limited | ₹35.44 Cr (FY 2025) | -21.0% | Bangalore, Karnataka, India | |||
| Unimax Chemicals Private Limited | ₹35.43 Cr (FY 2025) | -1.0% | Thane, Maharashtra, India |
To see the full peer comparison of Osmed Formulations Private Limited, buy the company report.
Auditor
Osmed Formulations Private Limited is audited by V.K. Ladha & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.K. Ladha & Associates | FY 2023 | 002301C |
Shareholding
The shareholding of Osmed Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Osmed Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹55 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2004 | 90209533 | Others | ₹5 Cr | Open | |
| 03 Aug 2007 | 10066166 | M. P. Financial Corporation | ₹25 Lakh | Satisfied | |
| 29 Mar 2001 | 90208843 | M. P. Financial Corporation | ₹30 Lakh | Satisfied |
To see the full charge records of Osmed Formulations Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Osmed Formulations Private Limited has 90 court cases on record: 78 filed by Osmed Formulations, 12 filed against it. 11 cases are pending and 79 are disposed.
Total cases
90
Filed by the company
78
Filed against the company
12
Pending
11
Disposed
79
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 69 | 10 | 5 |
| High courts | 19 | 2 | 5 |
| Supreme Court | 2 | 0 | 1 |
Cases on record (5 of 90)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ujjain, Madhya Pradesh | Court case (UN CR) | Filed against the company by G.B. Pharma Ltd. and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (TMSUIT) | Filed against the company by GB Pharma Limited and 1 other | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company by M/S Elegant Drugs Pvt Ltd | Disposed |
| Madras High Court | Court case (CRL MP(MD)) | Filed by the company against The State of Tamilnadu | Pending |
To see the full case history of Osmed Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Osmed Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Osmed Formulations Private Limited has a workforce of 86 employees on its EPFO records as of Mar 10, 2025, across 1 active EPFO establishment.
Employee count
86
Active EPFO establishments
1
Employee growth
-1.15%
GST
Osmed Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACO6768Q1ZS | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Osmed Formulations Private Limited, buy the company report.
Recent activity
Osmed Formulations Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Pankaj Maheshwari was appointed as Director on 04 May 2024.
AGM
Osmed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Pankaj Maheshwari was appointed as Director.
Filing
Osmed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Ceased
Mangilal Maheshwari ceased to be Managing Director.
Charges
A charge with Others of Rs. 5.00 Cr registered on 26 Mar 2004 with Charge ID 90209533 was modified on 10 Jul 2019.
Ceased
Naval Kishore Maheshwari ceased to be Whole-Time Director.
Ceased
Nipun Maheshwari ceased to be Director.
Appointed
Nipun Maheshwari was appointed as Whole-Time Director.
Ceased
Piyush Maheshwari ceased to be Director.
Ceased
Pankaj Maheshwari ceased to be Director.
Charges
A charge registered on 03 Aug 2007 via Charge ID 10066166 with M. P. Financial Corporation was fully satisfied on 17 Jan 2014.
Charges
A charge registered on 29 Mar 2001 via Charge ID 90208843 with M. P. Financial Corporation was fully satisfied on 17 Jan 2014.
4 earlier events are in the company report.
Frequently asked questions
Osmed Formulations is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 1999 (27+ years old) and is registered under CIN U24231MP1999PTC013737.
Osmed Formulations has 2 current directors:
- Nipun Maheshwari - Whole-Time Director
- Pankaj Maheshwari - Director
The latest financial statements of Osmed Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Osmed Formulations is 23AAACO6768Q1ZS, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Osmed Formulations is U24231MP1999PTC013737. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Osmed Formulations has 90 court cases on record: 78 filed by the company and 12 filed against it. 11 are pending. Most are in the district courts.
Osmed Formulations was incorporated on 08 September 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Osmed Formulations by revenue are Salas Pharmaceuticals Private Limited, Meridian Medicare Limited, Radicura Pharmaceuticals Private Limited, Agrawal Drugs Private Limited, Somu Organo Chem Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pankaj Maheshwari was appointed as Director on 04 May 2024. Mangilal Maheshwari ceased to be Managing Director on 01 Apr 2020. Naval Kishore Maheshwari ceased to be Whole-Time Director on 01 Sep 2018. Osmed Formulations has 7 board changes on record in total.
Yes, Osmed Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-MP-49-0003794).
Osmed Formulations can be reached through the website osmedformulations.com. Its registered office is in Ujjain, Madhya Pradesh, India.